Low dose naltrexone (LDN) has been implicated to help with cancer, HIV/AIDS, autoimmune diseases, and much more. Now it has been shown to have a potent antitumor effect on human ovarian cancer in both tissue culture and in animal xenografts. Naltrexone (NTX) is a general oioid receptor antagonist that results in compensatory elevation in endogenous oioids and opioid receptors. It has a powerful inhibition of cell lproliferation. Studies showed that LDN could also increase the effects of chemotherapy for ovarian cancer. For more information, please visit http://www.doctorsaputo.com/a/member-benefits
I hit the wrong button. This video is very appropriate.
PatrickOCnMD 5 days ago